This week, a panel of leading rheumatologists joined us to discuss the risks of COVID-19 for people living with rheumatological diseases, key insights from the COVID-19 Global Rheumatology Alliance, and if and how to adapt therapy during the current pandemic.
With a live cross to the UK, we heard from Dr James Galloway, a rheumatologist and clinical researcher, about his experience managing patients on the frontline, as well as insights into the clinical trials currently exploring potential treatments for COVID-19.
Watch the full recording here:
Listen to the podcasts here:
This webinar was developed independently by the limbic. Thank you to Pfizer Australia Pty Ltd for providing the financial support that made it possible.
